News

News
Partner news

Navitor Pharmaceuticals Initiates a Clinical Study of NV-5138, a Novel, Oral Small Molecule for Treatment-Resistant Depression

Read full story
Partner news

Dreem Announces $35 Million Financing from lead investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Bpifrance to Accelerate Innovations in the Field of Sleep Science

Read full story
JNJ Press releases

Johnson & Johnson Innovation Opens JLABS @ NYC in Collaboration with New York State and the New York Genome Center

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Launch of Shanghai Lung Cancer Innovation QuickFire Challenge

Read full story
Partner news

Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo

Read full story
Partner news

E-Scape Bio Obtains Worldwide Rights from AbbVie for Selective S1P5 Program Targeting CNS-related Lysosomal Storage Disorders

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Five-Year Alliance with Boston University to Accelerate Vision of World Without Lung Cancer

Read full story
JNJ Press releases

VIVUS Executes on its Strategic Vision with the Closing of its Acquisition of PANCREAZE® and Previously Announced Financing Transaction

Read full story
JNJ Press releases

James Allison, Ph.D., Wins 2018 Dr. Paul Janssen Award for Biomedical Research

Read full story
JNJ Press releases

Zebra Medical Vision raises $30 million

Read full story
Partner news

Israel's Zebra Medical Vision raises $30 million

Read full story
Partner news

BlackThorn Therapeutics Initiates Phase 1 Study of BTRX-335140, an Investigational Kappa Opioid Receptor (KOR) Antagonist

Read full story